sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology

Immunopharmacology and Immunotoxicology

Volumn 22, Issue 1, 2000, Pages 19-33

  Tortorella, Cosimo ^a   Sacco, Rodolfo ^a   Orlando, Piero ^a   Salerno, Maria Teresa ^a   Schiraldi, Oronzo ^a   Antonaci, Salvatore ^a,b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

HEPATITIS C VIRUS;

EID: 0034019652     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923970009016403     Document Type: Article

References (35)

1. Fiore, G., Angarano, L., Caccetta, L., Serrone, M., Jirillo, E., Schiraldi, O., Antonaci, S., In-situ immunophenotyping study of hepatic-infiltrating cells in chronic active hepatitis C, Eur. J. Hepatol. Gastroenterol., 9:491, 1997.
2. Khakoo, S.L, Soni, P.N., Savage, K., Brown, D., Dhillon, A.P., Poulter, L.W., Dusheiko, G.M., Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity, Am. J. Pathol., 150:963, 1997.
3. Simpson, K.J., Hayes, P.C., Soluble adhesion molecules in immune mediated liver diseases, Gut, 36:806, 1995.
4. Bach, N., Thung, S.N., Schaffner, F., The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis, Hepatology, 15:572, 1992.
5. Spengler, U., Leifeld, L., Braunschweiger, L, Dumoulin, F.L., Lechmann, M., Sauerbruch, T., Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis, J. Hepatol., 26:31, 1997.
6. Chedid, A., Mendenhall, C.L., Moritz, T.E., French, S.W., Chen, T.S., Morgan, T.R., Roselle, G.A., Nemchausky, B.A., Tamburro, C.H., Schiff, E.R., McClain, C.J., Marsano, L.S., Allen, J.I., Samanta, A., Weesner, R.E., Henderson, W.G., and Veterans Affairs Cooperative Study Group 275, Cell-mediated injury in alcoholic liver disease, Gastroenterology, 105:254, 1993.
7. Higaki, K., Yano, H., Kojiro, M., Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissue, Am. J. Pathol., 149:429, 1996.
8. Patel, T., Gores, G.J., Apoptosis and hepatobiliary disease, Hepatology, 21:1725, 1995.
9. Galle, P.R., Krammer, P.H., CD95-induced apoptosis in human liver disease, Semin. Liver Dis., 18:141, 1998.
10. Antonaci, S., Schiraldi, O., Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver - injury progression? A review, Immunopharmacol. Immunotoxicol., 20:455, 1998.
11. Mariani, S.M., Matiba, B., Baumler, C., Krammer, P.H., Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases, Eur. J. Immunol., 25:2303, 1995.
12. Cascino, I., Fucci, G., Papoff, G., Ruberti, G., Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing, J. Immunol., 154:2706, 1995.
13. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H., Nagata, S., Fas ligand in human serum, Nat. Med., 2:317, 1996.
14. Kaplanski, G., Famarier, C., Payan, M.J., Bongrand, P., Durand, J.M., Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis, Dig. Dis. Sci., 42:2277, 1997.
15. Piazzolla, G., Tortorella, C., Fiore, G., Serrone, M., Caccetta, L, Jirillo, E., Schiraldi, O., Antonaci, S., Immunoresponsiveness in Chronic Hepatitis C patients: correlation between tissue and serum findings, Immunopharmacol. Immunotoxicol., 20:337, 1998.
16. Simpson, K.J., Jones, A.L., Forbes Howie, A., Hayes, P.C., Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis, Eur. J. Gastrpenterol. Hepatol., 7:455, 1995.
17. Lim, A.G., Jazrawi, R.P., Ahmed, H.A., Levy, J.H., Zuin, M., Douds, A.C., Maxwell, J.D., Northfield, T.C., Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis, Hepatology, 20:882, 1994.
18. Douds, A.C., Lim, A.G., Jazrawi, R.P., Finlayson, C., Maxwell, J.D., Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity, J. Hepatol., 26:280, 1997.
19. Shimizu, Y., Minemura, M., Tsukishiro, T., Kashii, Y., Miyamoto, M., Nishimori, H., Higuchi, K., Watanabe, A., Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis, Hepatology, 22:525, 1995.
20. Johnson, P.J., McFarlane, I.G., Meeting report: International autoimmune hepatitis group, Hepatology, 18:998, 1993.
21. International Group, Alcoholic liver disease: morphological manifestations, Lancet, 1:707, 1981.
22. Rothlein, R., Mainolfi, E., Czajkowski, M., Marlin, S.D., A form of circulating ICAM-1 in human serum, J. Immunol., 147:3788, 1991.
23. Volpes, R., Van Der Oord, J.J., Desmet, V.J., Immunohistochemical study of adhesion molecules in liver inflammation, Hepatology, 12:59, 1990.
24. Volpes, R., Van Der Oord, J.J., Desmet, V.J., Vascular adhesion molecules in acute and chronic liver inflammation, Hepatology, 15:269, 1992.
25. Lim, A.G., Wolfhagen, H.J., Verma, A., Van Buuren, H.R., Jazrawi, R.P., Levy, J.H., Northfield, T.C., Schalm, S.W., Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy, Eur. J. Gastroenterol. Hepatol., 9:155, 1997.
26. Soresi, M., Cervello, M., Lipani, G., Carroccio, A., Cartabellotta, A., Marasa, L., Casto, C., Virruso, L., Montalto, G., Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma, Eur. J. Gastroenterol. Hepatol., 9:805, 1997.
27. Pirisi, M., Falletti, E., Fabris, C., Soardo, G., Toniutto, P., Vitulli, D., Pezzetta, F., Bortolotti, N., Gonano, F., Bartoli, E., Circulating intercellular adhesion molecule-1 (clCAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass, Am. J. Clin. Pathol., 102:600, 1994.
28. Luna-Casado, L., Diez-Ruiz, A., Gutierrez-Gea, F., Santos-Perez, J.L., Rico-Irles, J., Wachter, H., Fuchs, D., Increased peripheral mononuclear cells expression of adhesion molecules in alcoholic cirrhosis: its relation to immune activation, J. Hepatol., 27:477, 1997.
29. Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J., Mountz, J.D., Protection from Fas-mediated apoptosis by soluble form of the Fas molecule, Science, 263:1759, 1994.
30. lio, S., Hayashi, N., Mita, E., Ueda, K., Mochizuki, K., Hiramatsu, N., Kanto, T., Sasaki, Y., Kasahara, A., Hori, M., Serum levels of soluble Fas antigen in chronic hepatitis C patients, J. Hepatol., 29:517, 1998.
31. Fiore, G., Piazzolla, G., Galetta, V., Caccetta, L., Schiraldi, O., Antonaci, S., Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities, Microbios, 97:29, 1999.
32. Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, K., Runkel, L., Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage, J. Exp. Med., 182:1223, 1995.
33. Jodo, S., Kobayashi, S., Nakajima, Y., Matsunaga, T., Nakayama, N., Ogura, N., Kayagaki, N., Okumura, K., Koike, T., Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma, Clin. Exp. Immunol., 112:166, 1998.
34. Strand, S., Hofmann, W.J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H., Galle, P.R., Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion?, Nat. Med., 2:1361, 1996.
35. O'Connel, J., Bennet, M.W., O'Sullivan, G.C., Collins, U.K., Shanahan, F., The Fas counterattack: cancer as a site of immune privilege, Immunol. today, 20:46, 1999.